# A Clinical Study to Evaluate the Safety and Efficacy of JHM03 in Adult Patients With Upper Limb Spasticity

> **NCT06584240** · PHASE1,PHASE2 · COMPLETED · sponsor: **JHM BioPharma (Tonghua) Co. , Ltd.** · enrollment: 84 (actual)

## Conditions studied

- Upper Limb Spasticity

## Interventions

- **DRUG:** Sequence 1
- **DRUG:** Sequence 2
- **DRUG:** Sequence 3
- **DRUG:** Sequence 4
- **DRUG:** Sequence 5

## Key facts

- **NCT ID:** NCT06584240
- **Lead sponsor:** JHM BioPharma (Tonghua) Co. , Ltd.
- **Sponsor class:** NETWORK
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-14
- **Primary completion:** 2025-05-24
- **Final completion:** 2025-07-23
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2025-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06584240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06584240, "A Clinical Study to Evaluate the Safety and Efficacy of JHM03 in Adult Patients With Upper Limb Spasticity". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06584240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*